Aveanna Healthcare (NASDAQ:AVAH) Stock Price Down 7.6% – Time to Sell?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price fell 7.6% during trading on Monday . The stock traded as low as $6.67 and last traded at $6.6270. 1,037,217 shares changed hands during mid-day trading, a decline of 21% from the average session volume of 1,312,240 shares. The stock had previously closed at $7.17.

Analyst Upgrades and Downgrades

Several research firms recently commented on AVAH. Barclays cut their price target on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a research note on Monday, May 18th. Truist Financial boosted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research note on Wednesday, May 20th. Weiss Ratings cut Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Finally, BMO Capital Markets cut their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.50.

Aveanna Healthcare Stock Performance

The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a market capitalization of $1.46 billion, a P/E ratio of 5.63, a price-to-earnings-growth ratio of 0.85 and a beta of 1.93. The company has a fifty day moving average of $6.79 and a two-hundred day moving average of $7.78.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. The firm had revenue of $647.92 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.Aveanna Healthcare’s quarterly revenue was up 15.9% on a year-over-year basis. On average, equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.56 EPS for the current year.

Insider Activity at Aveanna Healthcare

In other news, insider Patrick A. Cunningham sold 125,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the transaction, the insider directly owned 212,755 shares of the company’s stock, valued at approximately $1,614,810.45. This represents a 37.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 5.30% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Aveanna Healthcare by 17.7% during the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock valued at $15,110,000 after purchasing an additional 278,429 shares during the last quarter. AustralianSuper Pty Ltd bought a new position in shares of Aveanna Healthcare during the third quarter valued at approximately $15,743,000. Nuveen LLC grew its holdings in shares of Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after purchasing an additional 905,316 shares during the last quarter. Finally, State Street Corp grew its holdings in shares of Aveanna Healthcare by 20.9% during the fourth quarter. State Street Corp now owns 1,483,265 shares of the company’s stock valued at $12,118,000 after purchasing an additional 256,392 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.